Nitric Oxide Impairs Normoxic Degradation of HIF-1α by Inhibition of Prolyl Hydroxylases
Open accessThe DOI matches its Crossref record; 61 of the 63 references it cites were found in a registry or an index.
Abstract
Hypoxia inducible factor-1 (HIF-1) is the master regulator of metabolic adaptation to hypoxia. It is appreciated that HIF-1alpha accumulation is achieved under normoxic conditions by e.g., nitric oxide. We determined molecular mechanisms of HIF-1alpha accumulation under the impact of S-nitrosoglutathione (GSNO). In human embryonic kidney cells GSNO provoked nuclear accumulation of HIF-1alpha. This appeared unrelated to gene transcription and protein translation, thus pointing to inhibition of HIF-1alpha degradation. Indeed, GSNO as well as the hypoxia mimic CoCl2 decreased ubiquitination of HIF-1alpha and GSNO-induced HIF-1alpha failed to coimmunoprecipitate with pVHL (von Hippel Lindau protein). Considering that HIF-1alpha-pVHL interactions require prolyl hydroxylation of HIF-1alpha, we went on to demonstrate inhibition of HIF-1alpha prolyl hydroxylases (PHDs) by GSNO. In vitro HIF-1alpha-pVHL interactions revealed that GSNO dose-dependently inhibits PHD activity but not the interaction of a synthetic peptide resembling the hydroxylated oxygen-dependent degradation domain of HIF-1alpha with pVHL. We conclude that GSNO-attenuated prolyl hydroxylase activity accounts for HIF-1alpha accumulation under conditions of NO formation during normoxia and that PHD activity is subject to regulation by NO.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In line with earlier findings (Metzen et al., 2003), we observed that LPS-triggered HIF1 a accumulation was partially reduced in DC treated with the inducible nitric oxide (NO) synthase 2 ( Nos2 ) inhibitor L-NIL (Figures 2L and S2D).”
From Ferritin-Mediated Iron Sequestration Stabilizes Hypoxia-Inducible Factor-1α upon LPS Activation in the Presence of Ample Oxygen (2015) · cites this paper as Metzen et al., 2003
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Molecular Cloning: A Laboratory Manual
Sambrook, J., Fritsch, E., & Maniatis, T. (1989) · UCLA - Biblioteca de Ciencias de la Salud · Cited by 133,589
Jaakkola, P., Mole, D. R., Tian, Y.-M., Wilson, M. I., Gielbert, J., Gaskell, S. J., Kriegsheim, A. V., Hebestreit, H. F., Mukherji, M., Schofield, C. J., et al. (2001) · Science · doi:10.1126/science.1059796 · Cited by 5,535 · cited 2×
“The impact of GSNO on PHD activity was tested in a GalDBD-HIF-1 549–582-pVHL in vitro interaction assay, performed as described previously (Jaakkola et al., 2001).”
BackgroundMethodThe tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis
Maxwell, P. H., Wiesener, M. S., Chang, G.-W., Clifford, S. C., Vaux, E. C., Cockman, M. E., Wykoff, C. C., Pugh, C. W., Maher, E. R., & Ratcliffe, P. J. (1999) · Nature · doi:10.1038/20459 · Cited by 5,180 · cited 2×
“The requirement of pVHL for HIF-1 degradation is underscored in cells that do not contain a functional pVHL, which leads to high levels of HIF-1 in normoxia (Maxwell et al., 1999; Krieg et al., 2000; Clifford et al., 2001).”
BackgroundHIFα Targeted for VHL-Mediated Destruction by Proline Hydroxylation: Implications for O 2 Sensing
Ivan, M., Kondo, K., Yang, H., Kim, W., Valiando, J., Ohh, M., Salic, A., Asara, J. M., Lane, W. S., & Kaelin Jr., W. G. (2001) · Science · doi:10.1126/science.1059817 · Cited by 4,735 · cited 2×
“In normoxia HIF-1α is hydroxylated at Pro564 and Pro402 which is required for pVHL binding (Ivan et al., 2001; Jaakkola et al., 2001; Masson et al., 2001; Yu et al., 2001).”
BackgroundEpstein, A. C. R., Gleadle, J. M., McNeill, L. A., Hewitson, K. S., O'Rourke, J., Mole, D. R., Mukherji, M., Metzen, E., Wilson, M. I., Dhanda, A., et al. (2001) · Cell · doi:10.1016/s0092-8674(01)00507-4 · Cited by 3,333
Self-citationBiochemistry of nitric oxide and its redox-activated forms
Stamler, J. S., Singel, D. J., & Loscalzo, J. (1992) · Science · doi:10.1126/science.1281928 · Cited by 2,744
A conserved family of prolyl-4-hydroxylases that modify HIF
Bruick, R. K., & McKnight, S. L. (2001) · Science · doi:10.1126/science.1066373 · Cited by 2,549 · cited 1×
“The human enzymes have been termed prolyl hydroxylase domain containing protein 1, 2, and 3 (PHD1, PHD2, and PHD3; Epstein et al., 2001) or HIF1 prolyl hydroxylase 1, 2, and 3 (Bruick and McKnight, 2001).”
Huang, L. E., Gu, J., Schau, M., & Bunn, H. F. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.14.7987 · Cited by 2,113 · cited 1×
“Consequently, HIF-1 is polyubiquitinated and degraded by the 26S proteasome system, thus accounting for its low normoxic level of expression (Salceda and Caro, 1997; Huang et al., 1998; Kallio et al., 1999).”
BackgroundPurification and Characterization of Hypoxia-inducible Factor 1
Wang, G. L., & Semenza, G. L. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.3.1230 · Cited by 2,073 · cited 1×
“HIF-1 is composed of the two basic helix-loop-helix-Per-Arnt-Sim (bHLH-PAS) proteins HIF-1 and the aryl hydrocarbon receptor nuclear translocator (ARNT), also known as HIF-1 (Wang and Semenza, 1995).”
BackgroundChandel, N. S., McClintock, D. S., Feliciano, C. E., Wood, T. M., Melendez, J. A., Rodriguez, A. M., & Schumacker, P. T. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m001914200 · Cited by 2,000
Cited by
Protein S-nitrosylation: Purview and parameters
Hess, D. T., Matsumoto, A., Kim, S.-O., Marshall, H. E., & Stamler, J. S. (2005) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1569 · Cited by 2,153
“Subsequently, it was reported that GSNO decreased the binding of HIFα and VHL, and therefore HIFα ubiquitylation, and that this effect was correlated with the ability of GSNO to inhibit the activity of prolyl hydoxylases in vitro”
BackgroundOxygen sensing by HIF hydroxylases
Schofield, C. J., & Ratcliffe, P. J. (2004) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1366 · Cited by 2,068
“Several studies of the HIF/hydroxylase pathway have shown both apparent inhibition of hydroxylation and activation of HIF transcriptional activity by different NO donor”
BackgroundRedox regulation of cell survival
Trachootham, D., Lu, W., Ogasawara, M. A., Valle, N. R.-D., & Huang, P. (2008) · Antioxidants & Redox Signaling · doi:10.1089/ars.2007.1957 · Cited by 1,781
“…of stimuli [including growth factors such as IGF-1, hormones, vasoactive peptides such as thrombin, metal ions such as CoCl 2 , H 2 O 2 , and certain NO donors such as S-nitrosoglutathione (GSNO) and NOC-18] are known to stabilize HIF, in part through increase ROS/RNS production (17, 100, 208).”
Hypoxia-Inducible Factor-1 (HIF-1)
Ke, Q., & Costa, M. (2006) · Molecular Pharmacology · doi:10.1124/mol.106.027029 · Cited by 1,646
“The transcription of FIH-1 is independent of the oxygen concentration, and it does not influence HIF-1 stability (Metzen et al., 2003a).”
InfluentialThe role of nitric oxide in tumour progression
Fukumura, D., Kashiwagi, S., & Jain, R. K. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1910 · Cited by 1,259
“It also impairs normoxic degradation of HIF1α by inhibiting the action of prolyl hydroxylase”
Integration of Oxygen Signaling at the Consensus HRE
Wenger, R. H., Stiehl, D. P., & Camenisch, G. (2005) · Science's STKE · doi:10.1126/stke.3062005re12 · Cited by 1,032
Radiation activates HIF-1 to regulate vascular radiosensitivity in tumors
Moeller, B. J., Cao, Y., Li, C. Y., & Dewhirst, M. W. (2004) · Cancer Cell · doi:10.1016/s1535-6108(04)00115-1 · Cited by 996
Reactive Oxygen Species: A Breath of Life or Death?
Fruehauf, J. P., & Meyskens, F. L. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-2082 · Cited by 915
Wound healing essentials: Let there be oxygen
Sen, C. K. (2009) · Wound Repair and Regeneration · doi:10.1111/j.1524-475x.2008.00436.x · Cited by 713
Chen, F., Chen, J., Yang, L., Liu, J., Zhang, X., Zhang, Y., Tu, Q., Yin, D., Lin, D., Wong, P.-P., et al. (2019) · Nature Cell Biology · doi:10.1038/s41556-019-0299-0 · Cited by 712
Hanschmann, E.-M., Godoy, J. R., Berndt, C., Hudemann, C., & Lillig, C. H. (2013) · Antioxidants & Redox Signaling · doi:10.1089/ars.2012.4599 · Cited by 677
Prabhakar, N. R., & Semenza, G. L. (2012) · Physiological Reviews · doi:10.1152/physrev.00030.2011 · Cited by 641
“Several different mechanisms of action have been proposed for induction of HIF-1 by NO, including S-nitrosylation of HIF-1 protein (192, 248), activation of the PI3K pathway (152, 286), inhibition of prolyl hydroxylase activity (227), and redistribution of intracellular O2 due to inhibition of mitochondrial respiratio…”
BackgroundHIF1 and oxygen sensing in the brain
Sharp, F. R., & Bernaudin, M. (2004) · Nature Reviews Neuroscience · doi:10.1038/nrn1408 · Cited by 568
“Moreover, NO emerged recently as a candidate molecule that provokes accumulation of HIF1α under normoxia through impairment of its degradation by inhibition of prolyl-hydroxylase”
BackgroundRegulation of immune cells by local-tissue oxygen tension: HIF1α and adenosine receptors
Sitkovsky, M., & Lukashev, D. (2005) · Nature Reviews Immunology · doi:10.1038/nri1685 · Cited by 518
“, because downregulation of these hydroxylases leads to accumulation of HIF1α and to corresponding changes in HIF1-dependent effector function”
Castello, P. R., David, P. S., McClure, T., Crook, Z., & Poyton, R. O. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.02.011 · Cited by 495
S -Nitrosylation in Cardiovascular Signaling
Lima, B., Forrester, M. T., Hess, D. T., & Stamler, J. S. (2010) · Circulation Research · doi:10.1161/circresaha.109.207381 · Cited by 490
Balligand, J.-L., Feron, O., & Dessy, C. (2009) · Physiological Reviews · doi:10.1152/physrev.00042.2007 · Cited by 477
“Interestingly, the NO-driven stabilization of HIF-1 was reported to occur under normoxic conditions (276, 360).”
BackgroundMovafagh, S., Crook, S., & Vo, K. (2015) · Journal of Cellular Biochemistry · doi:10.1002/jcb.25074 · Cited by 469
“NO has been shown to stabilize HIF-1a under both normoxia and hypoxia [Sandau et al., 2001; Mateo et al., 2003; Metzen et al., 2003].”
BackgroundProline hydroxylation and gene expression
Kaelin, W. G. (2005) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.74.082803.133142 · Cited by 468
Regulation of angiogenesis by hypoxia-inducible factor 1
Hirota, K., & Semenza, G. L. (2006) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2005.12.003 · Cited by 464
Regulation of HIF-1α Stability through S-Nitrosylation
Li, F., Sonveaux, P., Rabbani, Z. N., Liu, S., Yan, B., Huang, Q., Vujaskovic, Z., Dewhirst, M. W., & Li, C.-Y. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.02.024 · Cited by 437
“In tissue cultured cells, exogenously added nitric oxide has been found to increase HIF-1α through the inhibition of prolyl hydroxylase in vitro(Metzen et al., 2003).”
InfluentialBacterial lipopolysaccharide induces HIF-1 activation in human monocytes via p44/42 MAPK and NF-κB
Frede, S., Stockmann, C., Freitag, P., & Fandrey, J. (2006) · Biochemical Journal · doi:10.1042/bj20051839 · Cited by 436
Self-citationRole and regulation of prolyl hydroxylase domain proteins
Fong, G.-H., & Takeda, K. (2008) · Cell Death & Differentiation · doi:10.1038/cdd.2008.10 · Cited by 427
Reversible Inactivation of HIF-1 Prolyl Hydroxylases Allows Cell Metabolism to Control Basal HIF-1
Lu, H., Dalgard, C. L., Mohyeldin, A., McFate, T., Tait, A. S., & Verma, A. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m508718200 · Cited by 400
Fukuto, J. M., Carrington, S. J., Tantillo, D. J., Harrison, J. G., Ignarro, L. J., Freeman, B. A., Chen, A., & Wink, D. A. (2012) · Chemical Research in Toxicology · doi:10.1021/tx2005234 · Cited by 389
MARXSEN, J. H., STENGEL, P., DOEGE, K., HEIKKINEN, P., JOKILEHTO, T., WAGNER, T., JELKMANN, W., JAAKKOLA, P., & METZEN, E. (2004) · Biochemical Journal · doi:10.1042/bj20040620 · Cited by 386
Self-citationKorbecki, J., Simińska, D., Gąssowska-Dobrowolska, M., Listos, J., Gutowska, I., Chlubek, D., & Baranowska-Bosiacka, I. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221910701 · Cited by 380
Signalling hypoxia by HIF hydroxylases
Schofield, C. J., & Ratcliffe, P. J. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.08.111 · Cited by 341
Kaelin, W. G. (2007) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev.pathol.2.010506.092049 · Cited by 336
Nitric oxide signaling: Classical, less classical, and nonclassical mechanisms
Martínez-Ruiz, A., Cadenas, S., & Lamas, S. (2011) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.04.010 · Cited by 335
McMahon, S., Charbonneau, M., Grandmont, S., Richard, D. E., & Dubois, C. M. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m604507200 · Cited by 330
Metastasis: cancer cell’s escape from oxidative stress
Pani, G., Galeotti, T., & Chiarugi, P. (2010) · Cancer and Metastasis Reviews · doi:10.1007/s10555-010-9225-4 · Cited by 313
“On the other hand, hydrogen peroxide indirectly promotes HIF stabilization by oxidizing catalytic Fe++ of PHDs and inhibiting their activity [84].”
BackgroundInfluentialThe Redox Basis of Epigenetic Modifications: From Mechanisms to Functional Consequences
Cyr, A. R., & Domann, F. E. (2011) · Antioxidants & Redox Signaling · doi:10.1089/ars.2010.3492 · Cited by 297
Signaling pathways in cancer metabolism: mechanisms and therapeutic targets
You, M., Xie, Z., Zhang, N., Zhang, Y., Xiao, D., Liu, S., Zhuang, W., Li, L., & Tao, Y. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01442-3 · Cited by 292
Negative and positive regulation of HIF-1: A complex network
Bárdos, J. I., & Ashcroft, M. (2005) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2005.05.001 · Cited by 285
Chen, R., Lai, U. H., Zhu, L., Singh, A., Ahmed, M., & Forsyth, N. R. (2018) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2018.00132 · Cited by 269
“Metzen et al. (2003) found NO−, a reactive nitrogen species, caused HIF-1α accumulation in normoxia, due to decreased ubiquitination of HIF-1α, loss of HIF-1α-pVHL interaction and inhibition of HIF PHDs. Inducible nitric oxide synthase (iNOS) induced endogenous NO led to HIF accumulation in both…”
Myllyharju, J. (2008) · Annals of Medicine · doi:10.1080/07853890801986594 · Cited by 267
“Nitric oxide competes with the binding of oxygen to 2-oxoglutarate dioxygenases (23) and inhibits HIF-P4Hs under normoxic conditions (117,118).”
BackgroundHypoxia Inducible-Factor1α Regulates the Metabolic Shift of Pulmonary Hypertensive Endothelial Cells
Fijalkowska, I., Xu, W., Comhair, S. A. A., Janocha, A. J., Mavrakis, L. A., Krishnamachary, B., Zhen, L., Mao, T., Richter, A., Erzurum, S. C., et al. (2010) · The American Journal of Pathology · doi:10.2353/ajpath.2010.090832 · Cited by 263
MATEO, J., GARCÍA-LECEA, M., CADENAS, S., HERNÁNDEZ, C., & MONCADA, S. (2003) · Biochemical Journal · doi:10.1042/bj20031155 · Cited by 258
S-nitrosylation: a potential new paradigm in signal transduction
Martínez-Ruiz, A. (2004) · Cardiovascular Research · doi:10.1016/j.cardiores.2004.01.013 · Cited by 253
“The latter mechanism has been explained by NO-mediated inhibition of the Fe(2) dependent activity of the prolyl hydroxylases, which leads to accumulation of the HIF-a subunits [82,83].”
BackgroundHypoxia, hypoxia-inducible factors (HIF), HIF hydroxylases and oxygen sensing
Webb, J. D., Coleman, M. L., & Pugh, C. W. (2009) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-009-0147-7 · Cited by 253
“Proposed mechanisms include inhibition of HIF hydroxylases in normoxic conditions [165, 166], inducing HIF hydroxylase levels [167], possibly acting as partial HIF hydroxylase substrates in hypoxia and influencing intracellular oxygen levels available to the HIF hydroxylases by affecting mitochondrial function [168].”
BackgroundReview: Hypoxia-Inducible Factor-1 (HIF-1): A Novel Transcription Factor in Immune Reactions
Hellwig-Bürgel, T., Stiehl, D. P., Wagner, A. E., Metzen, E., & Jelkmann, W. (2005) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2005.25.297 · Cited by 254
Self-citationThe biphasic nature of nitric oxide responses in tumor biology
Ridnour, L. A., Thomas, D. D., Donzelli, S., Espey, M. G., Roberts, D. D., Wink, D. A., & Isenberg, J. S. (2006) · Antioxidants & Redox Signaling · doi:10.1089/ars.2006.8.1329 · Cited by 247
“Prolyl hydroxylases are nonheme Fe 2+ -containing proteins; the inhibitory affects of NO are proposed to involve competitive inhibition at the Fe 2+ -active site of the enzyme (47).”
Oxygen-dependent and tissue-specific regulation of erythropoietin gene expression
Fandrey, J. (2004) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00577.2003 · Cited by 243
“Affecting the redox state may indeed play a role in the recent report of direct inhibition of PHDs by NO (110).”
BackgroundSelf-citationHewitson, K. S., Liénard, B. M. R., McDonough, M. A., Clifton, I. J., Butler, D., Soares, A. S., Oldham, N. J., McNeill, L. A., & Schofield, C. J. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m608337200 · Cited by 235
iNOS as a metabolic enzyme under stress conditions
Anavi, S., & Tirosh, O. (2020) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2019.10.411 · Cited by 225
The chemistry of cell signaling by reactive oxygen and nitrogen species and 4-hydroxynonenal
Forman, H. J., Fukuto, J. M., Miller, T., Zhang, H., Rinna, A., & Levy, S. (2008) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2008.06.011 · Cited by 226
Glycolytic metabolism is essential for CCR7 oligomerization and dendritic cell migration
Guak, H., Al Habyan, S., Ma, E. H., Aldossary, H., Al-Masri, M., Won, S. Y., Ying, T., Fixman, E. D., Jones, R. G., McCaffrey, L. M., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-04804-6 · Cited by 224
Endogenous S -nitrosothiols protect against myocardial injury
Lima, B., Lam, G. K. W., Xie, L., Diesen, D. L., Villamizar, N., Nienaber, J., Messina, E., Bowles, D., Kontos, C. D., Hare, J. M., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0901043106 · Cited by 223
Nitric Oxide, Cytochrome C Oxidase, and the Cellular Response to Hypoxia
Taylor, C. T., & Moncada, S. (2010) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.108.181628 · Cited by 220
The von Hippel–Lindau protein, HIF hydroxylation, and oxygen sensing
Kaelin, W. G. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.08.165 · Cited by 214
Nitric oxide: role in tumour biology and iNOS/NO-based anticancer therapies
Singh, S., & Gupta, A. K. (2011) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-011-1654-4 · Cited by 212
“The inhibition of prolyl hydroxylase (PHD) activity by NO and activation of the PI3 K-Akt pathway were suggested to be involved in the regulation of HIF-1a stabilization by NO under these conditions [102].”
BackgroundHypoxic Radioresistance: Can ROS Be the Key to Overcome It?
Wang, H., Jiang, H., Van De Gucht, M., & De Ridder, M. (2019) · Cancers · doi:10.3390/cancers11010112 · Cited by 203
Yasuda, H. (2008) · Nitric Oxide · doi:10.1016/j.niox.2008.04.026 · Cited by 198
Mechanisms of adaptive angiogenesis to tissue hypoxia
Fong, G.-H. (2008) · Angiogenesis · doi:10.1007/s10456-008-9107-3 · Cited by 196
Molecular mechanisms for discrete nitric oxide levels in cancer
Ridnour, L. A., Thomas, D. D., Switzer, C., Flores-Santana, W., Isenberg, J. S., Ambs, S., Roberts, D. D., & Wink, D. A. (2008) · Nitric Oxide · doi:10.1016/j.niox.2008.04.006 · Cited by 196
HIF-1: the knowns and unknowns of hypoxia sensing.
Zagórska, A., & Dulak, J. (2004) · Acta Biochimica Polonica · doi:10.18388/abp.2004_3545 · Cited by 192
“Helpful in searching for the answer could be the fact that NO down-regulates HIF-1 in hypoxia by activation of PHDs in cytoplasmic extracts (Wang et al., 2002), although this effect has not been confirmed by in vitro protein interaction assays (Metzen et al., 2003b).”
BackgroundInfluentialZhang, P., Li, Y., Tang, Y., Shen, H., Li, J., Yi, Z., Ke, Q., & Xu, H. (2020) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.0c01792 · Cited by 189
Reactive oxygen species and cellular oxygen sensing
Cash, T. P., Pan, Y., & Simon, M. C. (2007) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2007.07.001 · Cited by 188
Epidermal Sensing of Oxygen Is Essential for Systemic Hypoxic Response
Boutin, A. T., Weidemann, A., Fu, Z., Mesropian, L., Gradin, K., Jamora, C., Wiesener, M., Eckardt, K.-U., Koch, C. J., Ellies, L. G., et al. (2008) · Cell · doi:10.1016/j.cell.2008.02.038 · Cited by 177
Yang, Y., Huang, K., Wang, M., Wang, Q., Chang, H., Liang, Y., Wang, Q., Zhao, J., Tang, T., & Yang, S. (2021) · Advanced Materials · doi:10.1002/adma.202103593 · Cited by 174
HIF-1 and tumour radiosensitivity
Moeller, B. J., & Dewhirst, M. W. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6603201 · Cited by 173
“& 2006 Cancer Research UK All rights reserved 0007 – 0920/06 $30.00 www.bjcancer.com Another suggests that reactive nitrogen species inhibit the cellular machinery that breaks down HIF-1 during normoxia, causing HIF-1 to function as though the cells were hypoxic (Metzen et al, 2003).”
InfluentialHIF hydroxylation and cellular oxygen sensing
Metzen, E., & Ratcliffe, P. J. (2004) · Biological Chemistry · doi:10.1515/bc.2004.016 · Cited by 172
Self-citationTumor hypoxia and radiotherapy: A major driver of resistance even for novel radiotherapy modalities
Beckers, C., Pruschy, M., & Vetrugno, I. (2024) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2023.11.006 · Cited by 167
Kaluz, S., Kaluzová, M., & Stanbridge, E. J. (2008) · Clinica Chimica Acta · doi:10.1016/j.cca.2008.05.002 · Cited by 165
“Nitric oxide also regulates the HIF system, presumably because it can act, at sufficiently high concentrations, as an analogue of molecular O2 and inhibit 2OG-dependent oxygenases [44].”
BackgroundHaddad, J. J., & Harb, H. L. (2005) · Molecular Immunology · doi:10.1016/j.molimm.2004.09.029 · Cited by 163
S-Nitrosothiols signal hypoxia-mimetic vascular pathology
Palmer, L. A., Doctor, A., Chhabra, P., Sheram, M. L., Laubach, V. E., Karlinsey, M. Z., Forbes, M. S., Macdonald, T., & Gaston, B. (2007) · Journal of Clinical Investigation · doi:10.1172/jci29444 · Cited by 161
Olson, N., & van der Vliet, A. (2011) · Nitric Oxide · doi:10.1016/j.niox.2010.12.010 · Cited by 156
Berchner-Pfannschmidt, U., Yamac, H., Trinidad, B., & Fandrey, J. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m607065200 · Cited by 155
Self-citationKakinuma, Y., Ando, M., Kuwabara, M., Katare, R. G., Okudela, K., Kobayashi, M., & Sato, T. (2005) · FEBS Letters · doi:10.1016/j.febslet.2005.02.065 · Cited by 152
“According to a report that NO attenuates the interaction between pVHL and HIF-1a through inhibiting PHD activity [21], it is possible that ACh may increase the HIF-1a protein level through NO.”
BackgroundSignaling and stress: The redox landscape in NOS2 biology
Thomas, D. D., Heinecke, J. L., Ridnour, L. A., Cheng, R. Y., Kesarwala, A. H., Switzer, C. H., McVicar, D. W., Roberts, D. D., Glynn, S., Fukuto, J. M., et al. (2015) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2015.06.002 · Cited by 150
Nitric oxide, apoptosis and macrophage polarization during tumor progression
Weigert, A., & Brüne, B. (2008) · Nitric Oxide · doi:10.1016/j.niox.2008.04.021 · Cited by 164
Self-citationMaloyan, A., Eli-Berchoer, L., Semenza, G. L., Gerstenblith, G., Stern, M. D., & Horowitz, M. (2005) · Physiological Genomics · doi:10.1152/physiolgenomics.00279.2004 · Cited by 146
Braverman, J., & Stanley, S. A. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1700515 · Cited by 143
Hypoxia-independent activation of HIF-1 by enterobacteriaceae and their siderophores
Hartmann, H., Eltzschig, H. K., Wurz, H., Hantke, K., Rakin, A., Yazdi, A. S., Matteoli, G., Bohn, E., Autenrieth, I. B., Karhausen, J., et al. (2008) · Gastroenterology · doi:10.1053/j.gastro.2007.12.008 · Cited by 143
Radiation damage and radioprotectants: new concepts in the era of molecular medicine
Koukourakis, M. I. (2012) · British Journal of Radiology · doi:10.1259/bjr/16386034 · Cited by 156
“Cobalt chloride (CoCl2), the iron chelator desferrioxamine, and the organomercurial compound mersalyl are important inducers of HIFs, which they achieve by mimicking hypoxia [35–37], probably by reducing the ubiquitination of HIF [38].”
BackgroundThe role of cellular oxidative stress in regulating glycolysis energy metabolism in hepatoma cells
Shi, D., Xie, F., Zhai, C., Stern, J. S., Liu, Y., & Liu, S. (2009) · Molecular Cancer · doi:10.1186/1476-4598-8-32 · Cited by 146
Iron and restless legs syndrome: treatment, genetics and pathophysiology
Connor, J. R., Patton, S. M., Oexle, K., & Allen, R. P. (2016) · Sleep Medicine · doi:10.1016/j.sleep.2016.07.028 · Cited by 152
Regulation of Hypoxia‐Inducible Factors During Inflammation
Frede, S., Berchner‐Pfannschmidt, U., & Fandrey, J. (2007) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(07)35021-0 · Cited by 162
Self-citationCytokines and the regulation of hypoxia-inducible factor (HIF)-1α
Haddad, J. J., & Harb, H. L. (2004) · International Immunopharmacology · doi:10.1016/j.intimp.2004.11.009 · Cited by 162
Hypoxia and Mucosal Inflammation
Colgan, S. P., Campbell, E. L., & Kominsky, D. J. (2016) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-012615-044231 · Cited by 132
“In terms of metabolic regulation, NO can cause an inhibition of prolyl hydroxylase enzymes in normoxia, leading to HIF stabilization (56).”
BackgroundDoege, K., Heine, S., Jensen, I., Jelkmann, W., & Metzen, E. (2005) · Blood · doi:10.1182/blood-2005-03-1138 · Cited by 128
Self-citationMuntané, J. (2010) · World Journal of Hepatology · doi:10.4254/wjh.v2.i9.337 · Cited by 128
Nitric oxide and superoxide: Interference with hypoxic signaling
BRUNE, B., & ZHOU, J. (2007) · Cardiovascular Research · doi:10.1016/j.cardiores.2007.03.005 · Cited by 125
“Addressing molecular mechanisms of NO action we showed decreased ubiquitination of HIF-1α and an abrogated binding of pVHL to HIF-1α [22], which implied that NO directly attenuates hydroxylation of HIF-1α.”
BackgroundSelf-citationDecoding microglial immunometabolism: a new frontier in Alzheimer's disease research
Jung, E. S., Choi, H., & Mook-Jung, I. (2025) · Molecular Neurodegeneration · doi:10.1186/s13024-025-00825-0 · Cited by 124
Superoxide fluxes limit nitric oxide-induced signaling
Thomas, D. D., Ridnour, L. A., Espey, M. G., Donzelli, S., Ambs, S., Hussain, S. P., Harris, C. C., DeGraff, W., Roberts, D. D., Mitchell, J. B., et al. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m602242200 · Cited by 121
The role of hypoxia and HIF-dependent signalling events in rheumatoid arthritis
Muz, B., Khan, M. N., Kiriakidis, S., & Paleolog, E. M. (2009) · Arthritis Research & Therapy · doi:10.1186/ar2568 · Cited by 131
“thought to involve at least in part stabilization of protein [35,40,41].”
BackgroundDevelopment of novel therapeutic strategies that target HIF-1
Semenza, G. L. (2006) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.10.2.267 · Cited by 120
“The administration of other NO donors to non-hypoxic cells inhibits prolyl hydroxylase activity by an undetermined mechanism [51].”
BackgroundBerberine inhibits HIF-1alpha expression via enhanced proteolysis.
Lin, S., Tsai, S.-C., Lee, C.-C., Wang, B.-W., Liou, J.-Y., & Shyu, K. (2004) · PubMed · Cited by 119
Hickok, J. R., Vasudevan, D., Antholine, W. E., & Thomas, D. D. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.432294 · Cited by 118
Regulated oxygen sensing by protein hydroxylation in renal erythropoietin-producing cells
Wenger, R. H., & Hoogewijs, D. (2010) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00736.2009 · Cited by 117
NO restores HIF-1α hydroxylation during hypoxia: Role of reactive oxygen species
Callapina, M., Zhou, J., Schmid, T., Köhl, R., & Brüne, B. (2005) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2005.05.009 · Cited by 132
“Mechanistically it is proposed that NO binds to the nonheme iron of PHD to block its activity, which results in HIF-1a stabilization [15].”
BackgroundSelf-citationS-nitrosylation: integrator of cardiovascular performance and oxygen delivery
Haldar, S. M., & Stamler, J. S. (2013) · Journal of Clinical Investigation · doi:10.1172/jci62854 · Cited by 127
FM19G11, a New Hypoxia-inducible Factor (HIF) Modulator, Affects Stem Cell Differentiation Status
Moreno-Manzano, V., Rodríguez-Jiménez, F. J., Aceña-Bonilla, J. L., Fustero-Lardíes, S., Erceg, S., Dopazo, J., Montaner, D., Stojkovic, M., & Sánchez-Puelles, J. M. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.008326 · Cited by 115
Baseler, W. A., Davies, L. C., Quigley, L., Ridnour, L. A., Weiss, J. M., Hussain, S. P., Wink, D. A., & McVicar, D. W. (2016) · Redox Biology · doi:10.1016/j.redox.2016.09.005 · Cited by 119
Sousa Fialho, M. D. L., Abd Jamil, A. H., Stannard, G. A., & Heather, L. C. (2019) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2018.09.024 · Cited by 112
Hypoxia inducible factor-1α is an important regulator of macrophage biology
Qiu, B., Yuan, P., Du, X., Jin, H., Du, J., & Huang, Y. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e17167 · Cited by 132
“However, PHD-dependent HIF-1α hydroxylation is inhibited under hypoxia, resulting in enhanced protein stability, nuclear translocation, and accumulation of HIF-1α [22,23].”
BackgroundWard, M. E., Toporsian, M., Scott, J. A., Teoh, H., Govindaraju, V., Quan, A., Wener, A. D., Wang, G., Bevan, S. C., Newton, D. C., et al. (2005) · Journal of Clinical Investigation · doi:10.1172/jci20806 · Cited by 111
“Potentially, therefore, feedback autoinhibition of nNOS expression may be affected at the transcriptional level through NO-dependent prolyl hydroxylase disinhibition and prevention of HIF-1α stabilization.”
BackgroundInfluentialTumor Cells Upregulate Normoxic HIF-1α in Response to Doxorubicin
Cao, Y., Eble, J. M., Moon, E., Yuan, H., Weitzel, D. H., Landon, C. D., Yu-Chih Nien, C., Hanna, G., Rich, J. N., Provenzale, J. M., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-1345 · Cited by 111
“found that NO impaired HIF-1α degradation under normoxic conditions (23).”
Siegert, I., Schödel, J., Nairz, M., Schatz, V., Dettmer, K., Dick, C., Kalucka, J., Franke, K., Ehrenschwender, M., Schley, G., et al. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.11.005 · Cited by 110
Metadata
- Authors
- Metzen, E., Zhou, J., Jelkmann, W., Fandrey, J., & Brüne, B.
- Affiliations
- University of Lübeck (DE)
- University of Kaiserslautern (DE)
- University of Duisburg-Essen (DE)
- Venue
- Molecular Biology of the Cell
- Published
- 2003-08
- Volume
- 14
- Issue
- 8
- Pages
- 3470-3481
- ISSN
- 1059-1524 (ISSN-L)
- 1939-4586
- PMC
- PMC181582
- OpenAlex
- W2072634616
- Cited by
- 414
- References
- 63
- Citations by year
- 2026: 10 · 2025: 14 · 2024: 10 · 2023: 13 · 2022: 7 · 2021: 22 · 2020: 13 · 2019: 12 · 2018: 9 · 2017: 12 · 2016: 23 · 2015: 19 · 2014: 10 · 2013: 14 · 2012: 17
- FWCI
- 9.57
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- Molecular Biology of the Cell (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Wellcome Trust
- European Molecular Biology Laboratory
- University of Oxford
- Deutsche Forschungsgemeinschaft (SFB367, BR999)
- Deutsche Krebshilfe
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Health Sciences › Medicine › Physiology (medical) › Nitric Oxide and Endothelin Effects
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Redox biology and oxidative stress
- Keywords
- nitric oxide, HIF-1α, prolyl hydroxylase, S-nitrosoglutathione, HIF-1α degradation, ubiquitination, von Hippel-Lindau protein, oxygen-dependent degradation domain, cobalt chloride, hypoxia, protein stability
- MeSH terms
- Cells, Cultured, Humans, Nitric Oxide, Procollagen-Proline Dioxygenase, Protein Binding, Transcription Factors, Transcription, Genetic, Protein Biosynthesis, Cell Hypoxia, Tumor Suppressor Proteins, S-Nitrosoglutathione, Ubiquitin-Protein Ligases, Von Hippel-Lindau Tumor Suppressor Protein, Hypoxia-Inducible Factor 1, alpha Subunit
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.